(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, has today announced the appointment of Mr. Albert Beraldo and Mr. George J. Anders to the board of directors. The appointments are effective as of January 28, 2016. At the same time, Mr. Gary Littlejohn and Mr. Yvon Bastien submitted their resignations to the board of directors for its consideration.
- 0 Comments
- FY2016